Laryngeal involvement of rhabdomyosarcoma in an adult

被引：6

作者：

Hüseyin Abali

Sercan Aksoy

Arzu Sungur

Suayib Yalçin

机构：

[1] Hacettepe University, Oncology Institute, Department of Medical Oncology, Ankara

[2] Hacettepe University, Faculty of Medicine, Department of Pathology, Ankara

来源：

World Journal of Surgical Oncology | / 1卷 / 1期

关键词：

Larynx; Metastatic; Primary; Rhabdomyosarcoma;

D O I：

10.1186/1477-7819-1-17

中图分类号：

学科分类号：

摘要：

Background: Although initial presentation of sarcomas in the head and neck region is relatively common, involvements of the larynx by rhabdomyosarcoma either primary or metastatic have been reported rarely. Case report: A case of rhabdomyosarcoma in the right thigh, which involved laryngeal structures three years after the diagnosis, is presented. Conclusions: The laryngeal involvement by primary and metastatic rhabdosarcomas is very rare, however when it occurs it can result in life treating upper airway obstruction. After emergency intervention, radiotherapy and / or chemotherapy must be undertaken for long-term benefit and surgery may be helpful only in selected cases. © 2003 Abali et al BioMed Central Ltd.

引用

页数：3

共 9 条

[1] Shaha A.R., Patel S., Shaha D., Harrison L.B., Head and neck cancer, Clinical Oncology, 2001, pp. 297-327
[2] Akyol M.U., Sozeri B., Kucukali T., Ogretmenoglu O., Laryngeal pleomorphic rhabdomyosarcoma, Eur. Arch. Otorhinolaryngol., 255, pp. 307-310, (1998)
[3] Rinaldo A., Howard D.J., Ferlito A., Laryngeal chondrosarcoma: A 24-year experience at the Royal National Throat, Nose and Ear Hospital, Acta Otolaryngol., 120, pp. 680-688, (2000)
[4] Puxeddu R., Pelagatti C.L., Ambu R., Colon adenocarcinoma metastatic to the larynx, Eur. Arch. Otorhinolaryngol., 254, pp. 353-355, (1997)
[5] Marcus K.C., Pediatric solid tumors, Clinical Oncology, 2001, pp. 577-609
[6] Gullu I., Yalcin S., Tekuzman G., Barista I., Alkis N., Celik I., Zengin N., Guler N., Kars A., Baltali E., Et al., High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas, Cancer Invest., 14, pp. 239-242, (1996)
[7] Barista I., Tekuzman G., Yalcin S., Gullu I., Guler N., Ozisik Y., Kars A., Celik I., Turker A., Altundag K., Zengin N., Uner A., Baltali E., Firat D., Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy, J. Surg. Onco., 73, pp. 12-16, (2000)
[8] Yalcin S., Gullu I., Barista I., Tekuzman G., Ozisik Y., Celik I., Kars A., Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy, Cancer Invest., 16, pp. 297-302, (1998)
[9] Yalcin S., Barista I., Tekuzman G., Gullu I., Fyrat D., Dramatic response to ifosfamide, mesna and doxorubicine chemotherapy regimen in an adult with clear cell sarcoma of the kidney, Journal of Urology, 155, (1996)

← 1 →